Intravitreal pegaptanib for the treatment of ischemic diabetic macular edema.
about
Chemical Modifications of Nucleic Acid Aptamers for Therapeutic Purposes.The Bioactivity of D-/L-Isonucleoside- and 2'-Deoxyinosine-Incorporated Aptamer AS1411s Including DNA Replication/MicroRNA Expression.Pharmacokinetics of intravitreal anti-VEGF drugs in vitrectomized versus non-vitrectomized eyes.
P2860
Intravitreal pegaptanib for the treatment of ischemic diabetic macular edema.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Intravitreal pegaptanib for the treatment of ischemic diabetic macular edema.
@ast
Intravitreal pegaptanib for the treatment of ischemic diabetic macular edema.
@en
type
label
Intravitreal pegaptanib for the treatment of ischemic diabetic macular edema.
@ast
Intravitreal pegaptanib for the treatment of ischemic diabetic macular edema.
@en
prefLabel
Intravitreal pegaptanib for the treatment of ischemic diabetic macular edema.
@ast
Intravitreal pegaptanib for the treatment of ischemic diabetic macular edema.
@en
P2093
P2860
P50
P356
P1476
Intravitreal pegaptanib for the treatment of ischemic diabetic macular edema
@en
P2093
Alexina Fantato
Lewis Smith
Rupal Morjaria
P2860
P304
P356
10.2147/OPTH.S90322
P407
P577
2015-12-11T00:00:00Z